Name: UMIN ID:
Unique ID issued by UMIN | UMIN000012720 |
---|---|
Receipt number | R000013947 |
Scientific Title | Pharmacogenomics study of gemcitabine on the safety and efficacy in metastatic pancreatic cancer patients |
Date of disclosure of the study information | 2014/01/01 |
Last modified on | 2021/06/08 15:28:02 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2013/12/28 09:04:49 | ||
2 | Update | 2014/01/06 11:09:29 | Recruitment status |
|
3 | Update | 2014/06/30 09:11:49 | Key inclusion criteria Key inclusion criteria |
|
4 | Update | 2016/01/25 18:19:33 | Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2017/01/01 23:26:18 | Name of primary person or sponsor Institute Department Organization |
|
6 | Update | 2020/07/03 09:18:12 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Name of primary person or sponsor Organization Organization Address Address Tel |
|
7 | Update | 2020/07/03 09:34:00 | Date of IRB Anticipated trial start date Last follow-up date |
|
8 | Update | 2021/06/08 15:28:02 | Recruitment status |